Drug usage and costs of children inpatients with bronchopneumonia in Karamay Central Hospital in 2014_Chinese Journal of Evidence-Based Medicine

Authors：

LIU Jianhong ¹ , YU Jiajie ² ,  ZHANG Weidong ¹ ,  LI Youping ² , WU Min ¹ , XU Ting ³ , XIE Yong ⁴ , LU Jing ³ , ZHANG Shengzhao ¹ , SUN Xin ² , SU Guanyue ²

1. Department of Pharmacy, Karamay Central Hospital, Karamay, 834000, P.R.China;
2. Chinese Evidence-Based Medicine Center, West China Hospital, Sichuan University, Chengdu, 610041, P.R.China;
3. Department of Pharmacy, West China Hospital, Sichuan University, Chengdu, 610041, P.R.China;
4. Department of Pediatrics, Karamay Central Hospital, Karamay, 834000, P.R.China;

Corresponding author：

ZHANG Weidong, Email: 0990end@sohu.com.cn; LI Youping, Email: yzmylab@hotmail.com

Keywords：

Children; Inpatients; Single disease; Bronchopneumonia; Evidence-based pharmacy; Rational drug use

DOI：

10.7507/1672-2531.201608044

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To investigate drug usage and costs of children inpatients with bronchopneumonia in Karamay Central Hospital in 2014 and to provide baseline for evidence-based pharmacy study of single disease in respiratory system. Methods The information of drug use and expenditure of children inpatients with bronchopneumonia were collected from the hospital information system (HIS). We analyzed the data including frequency, proportion and cumulative proportion by Excel 2007 software. Results A total of 890 children inpatients were included, the average age was 1.00±2.17 years old. Among the antibiotics of single therapy, the frequency of amoxicillin and clavulanate potassium for injection was highest. Among the antibiotics of combination therapy, the frequency of macrolides was highest. Conclusion The mainly drugs for treatment of children inpatients with bronchopneumonia in Karamay Central Hospital in 2014 is amoxicillin and clavulanate potassium for injection.

Citation： LIU Jianhong, YU Jiajie, ZHANG Weidong, LI Youping, WU Min, XU Ting, XIE Yong, LU Jing, ZHANG Shengzhao, SUN Xin, SU Guanyue. Drug usage and costs of children inpatients with bronchopneumonia in Karamay Central Hospital in 2014. Chinese Journal of Evidence-Based Medicine, 2017, 17(8): 876-879. doi: 10.7507/1672-2531.201608044 Copy

1.	国家卫生和计划生育委员会. 中国卫生和计划生育统计年鉴. 北京: 中国协和医科大学出版社, 2014: 113-114.
2.	张卫东, 喻佳洁, 刘建红, 等. 克拉玛依市中心医院 2014 年住院患者呼吸系统疾病构成和费用分析. 中国循证医学杂志, 2017, 17(5): 507-510.
3.	冯江, 刘凤玲, 衡萍, 等. 衡阳市某院 2013 年儿童疾病构成分析. 中国病案, 2015, 16(4): 53-55.
4.	中华医学会儿科学分会呼吸学组, 《中华儿科杂志》编辑委员会. 儿童社区获得性肺炎管理指南(2013 修订) (上). 中华儿科杂志, 2013, 51(10): 745-752.
5.	中华医学会儿科学分会呼吸学组, 《中华儿科杂志》编辑委员会. 儿童社区获得性肺炎管理指南(2013 修订) (下). 中华儿科杂志, 2013, 51(11): 856-862.
6.	Tapiainen T, Aittoniemi J, Immonen J, et al. Finnish guidelines for the treatment of community-acquired pneumonia and pertussis in children. Acta Pediatrica, 2016, 105(1): 39-43.
7.	Bradley JS, Byington CL, Shah SS, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the pediatric infectious diseases society and the infectious diseases society of America. Clin Infect Dis, 2011, 53(7): 25-76.
8.	Harris M, Clark J, Coote N, et al. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax, 2011, 66(Suppl 2): 1-23.
9.	Zar HJ, Jeena P, Argent A, et al. Diagnosis and management of community-acquired pneumonia in childhood-South African Thoracic Society Guidelines. S Afr Med J, 2005, 95(12 Pt 2): 977-981, 984-990.
10.	孙博文, 董碧蓉. 糖皮质激素临床滥用现状及合理应用原则. 现代临床医学, 2014, 40(2): 154-156.

1. 国家卫生和计划生育委员会. 中国卫生和计划生育统计年鉴. 北京: 中国协和医科大学出版社, 2014: 113-114.
2. 张卫东, 喻佳洁, 刘建红, 等. 克拉玛依市中心医院 2014 年住院患者呼吸系统疾病构成和费用分析. 中国循证医学杂志, 2017, 17(5): 507-510.
3. 冯江, 刘凤玲, 衡萍, 等. 衡阳市某院 2013 年儿童疾病构成分析. 中国病案, 2015, 16(4): 53-55.
4. 中华医学会儿科学分会呼吸学组, 《中华儿科杂志》编辑委员会. 儿童社区获得性肺炎管理指南(2013 修订) (上). 中华儿科杂志, 2013, 51(10): 745-752.
5. 中华医学会儿科学分会呼吸学组, 《中华儿科杂志》编辑委员会. 儿童社区获得性肺炎管理指南(2013 修订) (下). 中华儿科杂志, 2013, 51(11): 856-862.
6. Tapiainen T, Aittoniemi J, Immonen J, et al. Finnish guidelines for the treatment of community-acquired pneumonia and pertussis in children. Acta Pediatrica, 2016, 105(1): 39-43.
7. Bradley JS, Byington CL, Shah SS, et al. The management of community-acquired pneumonia in infants and children older than 3 months of age: clinical practice guidelines by the pediatric infectious diseases society and the infectious diseases society of America. Clin Infect Dis, 2011, 53(7): 25-76.
8. Harris M, Clark J, Coote N, et al. British Thoracic Society guidelines for the management of community acquired pneumonia in children: update 2011. Thorax, 2011, 66(Suppl 2): 1-23.
9. Zar HJ, Jeena P, Argent A, et al. Diagnosis and management of community-acquired pneumonia in childhood-South African Thoracic Society Guidelines. S Afr Med J, 2005, 95(12 Pt 2): 977-981, 984-990.
10. 孙博文, 董碧蓉. 糖皮质激素临床滥用现状及合理应用原则. 现代临床医学, 2014, 40(2): 154-156.

Chinese Journal of Evidence-Based Medicine

Drug usage and costs of children inpatients with bronchopneumonia in Karamay Central Hospital in 2014

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content